Nogo-A has been demonstrated to block neuronal and non-neuronal cell migration and spreading in vitro, which could have crucial consequences in CNS illnesses requiring angiogenesis, such as stroke, nerve injury, and retinal diseases [11, 12]. Here, RTN4 is linked to stroke disorder.